Anti-HPV59 L1 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22370; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-HPV59 L1 Polyclonal Antibody: A Powerful Tool for HPV Research and Detection
Human Papillomavirus (HPV) is a common sexually transmitted infection that can cause various health issues, including cervical cancer. Among the many types of HPV, HPV59 has been identified as one of the high-risk strains associated with cervical cancer. Therefore, accurate detection and monitoring of HPV59 is crucial for early diagnosis and prevention of cervical cancer. Our Anti-HPV59 L1 Polyclonal Antibody is a highly specific and reliable tool for researchers and clinicians to study and detect HPV59.
The Anti-HPV59 L1 Polyclonal Antibody is designed to target the L1 protein of HPV59. The L1 protein is a major structural protein of HPV and is essential for viral entry and replication. By targeting this protein, our antibody can effectively detect and bind to HPV59, allowing for its detection and identification.
Our Anti-HPV59 L1 Polyclonal Antibody has a wide range of applications in HPV research and detection. Some of the main applications include:
1. HPV59 Detection: The antibody can be used in various diagnostic tests, such as ELISA, Western blotting, and immunofluorescence, to detect the presence of HPV59 in clinical samples.
2. HPV59 Vaccine Development: The L1 protein is a major component of HPV vaccines. Our antibody can be used to evaluate the efficacy of HPV59 vaccines by detecting the presence of L1 protein in vaccinated individuals.
3. HPV59 Pathogenesis Studies: The antibody can also be used in research studies to understand the role of HPV59 in the development of cervical cancer and other HPV-related diseases.
Our Anti-HPV59 L1 Polyclonal Antibody has been extensively tested and validated in various experimental settings. Some of the use cases include:
1. HPV59 Cell Culture Studies: The antibody has been used in cell culture studies to detect the expression of L1 protein in HPV59-infected cells.
2. Clinical Sample Analysis: Our antibody has been successfully used in clinical samples, such as cervical swabs and tissue sections, to detect HPV59 and assess its prevalence in different populations.
3. Vaccine Efficacy Testing: The antibody has been used in clinical trials to evaluate the efficacy of HPV59 vaccines by measuring the levels of L1 protein in vaccinated individuals.
Conclusion:
In conclusion, our Anti-HPV59 L1 Polyclonal Antibody is a highly specific and sensitive tool for HPV research and detection. Its ability to target the L1 protein of HPV59 makes it a valuable asset in understanding the role of this high-risk strain in cervical cancer and other HPV-related diseases. With its versatile applications and proven experimental use cases, our antibody is a must-have for any researcher or clinician working with HPV59. Order now and take a step towards advancing HPV research and improving patient outcomes.
ProteoGenix catalogue number ARO-A22370. For research use only.
Target: hypothetical protein QKB50_gp8, ORF putative L1; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| hypothetical protein QKB50_gp8, ORF putative L1 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
